Skip to search formSkip to main contentSkip to account menu

Vemurafenib Oral Tablet [Zelboraf]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic… 
2011
2011
Two novel cancer drugs and their companion diagnostics to predict treatment response were given a go-ahead to market in quick…